PwC announces Check-In digital platform
Check-In, from BioCT member pwc, is a precision platform made up of two products built with people’s privacy in mind. The platform provides businesses with near real-time...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Check-In, from BioCT member pwc, is a precision platform made up of two products built with people’s privacy in mind. The platform provides businesses with near real-time...
A New Haven company has been granted up to $1.3 million from a national Alzheimer’s disease accelerator to advance its work developing a mobile app...
Antiviral developer NanoViricides says it has inked a confidential disclosure agreement with a “leading pharmaceutical company” in Asia to explore collaborating on the Shelton company’s proposed COVID-19...
Alexion will acquire Portola, a California-based commercial-stage biopharmaceutical company focused on life-threatening blood-related disorders. Portola’s commercialized medicine, Andexxa®, is the first and only approved Factor Xa...
BARDA has awarded Tangen Biosciences the Second Option of a contract to develop a molecular diagnostic platform that can be used by the company to rapidly...
Pfizer and BioNTech SE report that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program...
Alexion Pharmaceuticals plans to launch a Phase 3 clinical trial to see if its rare-disease drug ULTOMIRIS® can ease the severe immune response that can lead...
In the midst of their $500 million program to build a Covid-19 vaccine with BioNTech, Pfizer has announced a sizable deal to commercialize a vaccine...
A medical technology company, Convexity Scientific, is relocating to New Haven this spring. The company makes devices to help people with respiratory ailments. Geoff Matous,...
CytoVeris has recently raised $3.7 million, the company reports in an SEC filing. Founded in 2018 by Alan Kersey, the Farmingto biotech is developing a tumor...